- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Kodak improves screen technology for standard radiographic films
Better chemistry makes sharper imagesIn the increasingly digital world of radiology, it is easy to overlook technologies that seem linked to the past. Yet film, which has served physicians for more than a century, still has some
Better chemistry makes sharper images
In the increasingly digital world of radiology, it is easy to overlook technologies that seem linked to the past. Yet film, which has served physicians for more than a century, still has some advantages over digital technology, and it continues to evolve.
Kodak announced at the RSNA meeting a new screen-film technology that promises to deliver images 20% sharper than those produced with the company's previous film products.
The new X-Sight screen features smaller phosphor particles that facilitate modulation transfer function, which improves x-ray absorption and reduces image noise. The new X-Sight screen complements Kodak's zero crossover film technology that minimizes light scatter.
The X-Sight technology helps damp out blur and noise to better visualize structures in areas of high contrast or density, according to Eileen Heizyk, worldwide marketing manager for Kodak film systems.
"By working on producing sharper images, we are continuing our investment in analog film and striving to get analog imaging where it should be," she said.
The latest iteration of X-Sight is available for window and windowless cassettes. It is being sold at the same price as the previous product.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
